Back to Search Start Over

Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche's Endocannabinoid System Projects.

Authors :
Aebi J
Atz K
Ametamey SM
Benz J
Blaising J
Butini S
Campiani G
Carreira EM
Collin L
De Lago E
Gazzi T
Gertsch J
Gobbi L
Guba W
Fernández-Ruiz J
Fingerle J
Haider A
He Y
Heitman LH
Honer M
Hunziker D
Kuhn B
Maccarrone M
Märki HP
Martin RE
Mohr P
Mu L
Nazaré M
Nippa DF
Oddi S
O'Hara F
Pacher P
Romero J
Röver S
Rufer AC
Schibli R
Schneider G
Stepan AF
Sykes DA
Ullmer C
Van der Stelt M
Veprintsev DB
Wittwer MB
Grether U
Source :
Chimia [Chimia (Aarau)] 2024 Aug 21; Vol. 78 (7-8), pp. 499-512. Date of Electronic Publication: 2024 Aug 21.
Publication Year :
2024

Abstract

The endocannabinoid system (ECS) is a critical regulatory network composed of endogenous cannabinoids (eCBs), their synthesizing and degrading enzymes, and associated receptors. It is integral to maintaining homeostasis and orchestrating key functions within the central nervous and immune systems. Given its therapeutic significance, we have launched a series of drug discovery endeavors aimed at ECS targets, including peroxisome proliferator-activated receptors (PPARs), cannabinoid receptors types 1 (CB1R) and 2 (CB2R), and monoacylglycerol lipase (MAGL), addressing a wide array of medical needs. The pursuit of new therapeutic agents has been enhanced by the creation of specialized labeled chemical probes, which aid in target localization, mechanistic studies, assay development, and the establishment of biomarkers for target engagement. By fusing medicinal chemistry with chemical biology in a comprehensive, translational end-to-end drug discovery strategy, we have expedited the development of novel therapeutics. Additionally, this strategy promises to foster highly productive partnerships between industry and academia, as will be illustrated through various examples.<br /> (Copyright 2024 Johannes Aebi, Kenneth Atz, Simon M. Ametamey, Jörg Benz, Julie Blaising, Stefania Butini, Giuseppe Campiani, Erick M. Carreira, Ludovic Collin, Eva de Lago, Thais Gazzi, Jürg Gertsch, Luca Gobbi, Wolfgang Guba, Javier Fernández-Ruiz, Jürgen Fingerle, Ahmed Haider, Yingfang He, Laura H. Heitman, Michael Honer, Daniel Hunziker, Bernd Kuhn, Mauro Maccarrone, Hans Peter Märki, Rainer E. Martin, Peter Mohr, Linjing Mu, Marc Nazaré, David F. Nippa, Sergio Oddi, Fionn O’Hara, Pal Pacher, Julian Romero, Stephan Röver, Arne C. Rufer, Roger Schibli, Gisbert Schneider, Antonia F. Stepan, David A. Sykes, Christoph Ullmer, Mario van der Stelt, Dmitry B. Veprintsev, Matthias B. Wittwer, Uwe Grether. License: This work is licensed under a Creative Commons Attribution 4.0 International License.)

Details

Language :
English
ISSN :
0009-4293
Volume :
78
Issue :
7-8
Database :
MEDLINE
Journal :
Chimia
Publication Type :
Academic Journal
Accession number :
39221845
Full Text :
https://doi.org/10.2533/chimia.2024.499